Figure 2.

M10 decreased the severity of ulcerative colitis in colorectal tissues. The representative of H&E-stained colorectal tissues of normal mice (A); Model mice (B); Myricetin-treated mice (C); M10-treated mice by 25, 50, and 100 mg/kg (D–F), respectively; and Mesalazine-treated mice, ×100 (above), ×400 (bottom) (G); The pathological scores of chronic inflammation in colorectal tissues in each group (H), *p < 0.05, **p < 0.01 vs. model mice as well as Mesalazine-treated mice.